PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40181190,Protein aggregation identified in olfactory neuronal cells is associated with cognitive impairments in a subset of living schizophrenia patients.,2025,Carlos Ayala-Grosso,"Unit of Cellular Therapy, Centre of Experimental Medicine, Instituto Venezolano de Investigaciones Cientificas, Caracas, Venezuela.",nucifora@jhmi.edu.
40180935,Cutaneous melanoma.,2025,Dagmar Whitaker,"Melanoma Advisory Board South Africa, Cape Town, South Africa.",alpaslan.tasdogan@uk-essen.de.
40180925,Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation.,2025,Federico Lussana; Giuseppe Gritti; Silvia Ferrari; Gian Maria Borleri; Benedetta Rambaldi; Giuliana Rizzuto; Anna Grassi; Muriel Paganessi; Cristian Meli; Giulia Risca; Chiara Capelli; Elisa Gotti; Martino Introna; Jos√©e Golay; Alessandro Rambaldi,"Hematology and Bone Marrow Transplant Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Biostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; USS Centro di Terapia Cellulare ""G. Lanzani"", Bergamo, Italy.",abiondi.unimib@gmail.com.
40180903,Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial.,2025,Prapti A Patel; Sonja G Marcus; Leonard Rosenberg; Ashley O Yocum,"Leukemia and Lymphoma Society, Rye Brook, NY, USA.; Servier Pharmaceuticals, LLC, Boston, MA, USA.",yazan.madanat@utsouthwestern.edu.
40180902,Venetoclax schedule in AML: 7 vs 14 vs 21 vs 28 days.,2025,Naseema Gangat; Ayalew Tefferi,"Division of Hematology, Mayo Clinic, Rochester, MN, USA. gangat.naseema@mayo.edu.; Division of Hematology, Mayo Clinic, Rochester, MN, USA.",gangat.naseema@mayo.edu.
40180682,Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial.,2025,Jose De La Cerda; Laurence Belkoff; Elan Diamond; James D'Olimpio; Curtis Dunshee; Lawrence Gervasi; David Morris; Paul Sieber; Ronald Tutrone; Michael Ryan; Yi Zhong; Mike Ufer,"MidLantic Urology/Solaris Health, Bala Cynwyd, PA, USA.; Arizona Urology Specialists, Tucson, AZ, USA.; Urology Associates, PC, Nashville, TN, USA.; Keystone Urology Specialists, Lancaster, PA, USA.; Chesapeake Urology Research Associates, Towson, MD, USA.; Sumitomo Pharma Switzerland GmbH, Basel, Switzerland.; Sumitomo Pharma America Inc., Marlborough, MA, USA.; Clinical Research Alliance, Inc., Westbury, NY, USA.; SouthWest Urology LLC, Middleburg Heights, OH, USA.; Urology San Antonio, 3327 Research Plaza Suite 403, San Antonio, TX, 78235, USA. Jose.DeLaCerda@urologysa.com.; Pfizer Inc., New York, NY, USA.; New Jersey Urology, Saddle Brook, NJ, USA.",Jose.DeLaCerda@urologysa.com.
40180671,The Financial Toxicity of Hepatopancreatobiliary Cancer: An Analysis of the 1997-2023 National Health Interview Survey.,2025,Thomas B Cwalina,"Division of General Internal Medicine, Weill Cornell Medicine, New York, NY, USA.",dxzheng@mgh.harvard.edu.
